Hyperlipasemia in absence of acute pancreatitis is associated with elevated D-dimer and adverse outcomes in COVID 19 disease
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Pancreatology
- Vol. 21 (4) , 698-703
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysisGastroenterology, 2020
- Potential Effects of Coronaviruses on the Cardiovascular SystemJAMA Cardiology, 2020
- Central nervous system manifestations of COVID-19: A systematic reviewJournal of the Neurological Sciences, 2020
- Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the pastJournal of Clinical Virology, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled AnalysisThrombosis and Haemostasis, 2020
- First Case of 2019 Novel Coronavirus in the United StatesNew England Journal of Medicine, 2020
- Defining the diagnostic value of hyperlipasemia for acute pancreatitis in the critically illPancreatology, 2017
- Significant elevations of serum lipase not caused by pancreatitis: a systematic reviewHPB, 2015
- Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensusGut, 2012